Malaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments

Fukuda, Mark M.; Klein, Terry A.; Kochel, Tadeusz; Quandelacy, Talia M.; Smith, Bryan L.; Villinski, Jeff; Bethell, Delia; Tyner, Stuart; Youry Se; Lon, Chanthap; Saunders, David; Johnson, Jacob; Wagar, Eric; Walsh, Douglas; Kasper, Matthew; Sanchez, Jose L.; Witt, Clara J.; Qin Cheng; Waters, Norman; Shrestha, Sanjaya K.
January 2011
BMC Public Health;2011 Supplement 2, Vol. 11 Issue Suppl 2, p1
Academic Journal
Vector-borne infections (VBI) are defined as infectious diseases transmitted by the bite or mechanical transfer of arthropod vectors. They constitute a significant proportion of the global infectious disease burden. United States (U.S.) Department of Defense (DoD) personnel are especially vulnerable to VBIs due to occupational contact with arthropod vectors, immunological naiveté to previously unencountered pathogens, and limited diagnostic and treatment options available in the austere and unstable environments sometimes associated with military operations. In addition to the risk uniquely encountered by military populations, other factors have driven the worldwide emergence of VBIs. Unprecedented levels of global travel, tourism and trade, and blurred lines of demarcation between zoonotic VBI reservoirs and human populations increase vector exposure. Urban growth in previously undeveloped regions and perturbations in global weather patterns also contribute to the rise of VBIs. The Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) and its partners at DoD overseas laboratories form a network to better characterize the nature, emergence and growth of VBIs globally. In 2009 the network tested 19,730 specimens from 25 sites for Plasmodium species and malaria drug resistance phenotypes and nearly another 10,000 samples to determine the etiologies of non-Plasmodium species VBIs from regions spanning from Oceania to Africa, South America, and northeast, south and Southeast Asia. This review describes recent VBI-related epidemiological studies conducted by AFHSC-GEIS partner laboratories within the OCONUS DoD laboratory network emphasizing their impact on human populations.


Related Articles

  • Malaria Rapid Diagnostic Tests. Wilson, Michael L. // Clinical Infectious Diseases;Jun2012, Vol. 54 Issue 11, p1637 

    Global efforts to control malaria are more complex than those for other infectious diseases, in part because of vector transmission, the complex clinical presentation of Plasmodium infections, >1 Plasmodium species causing infection, geographic distribution of vectors and infection, and drug...

  • Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana. Mockenhaupt, Frank P.; Bousema, J. Teun; Eggelte, Teunis A.; Ehrhardt, Stephan; Otchwemah, Rowland N.; Sauerwein, Robert W.; Bienzle, Ulrich // Malaria Journal;2005, Vol. 4, p1 

    Background: Both chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) are failing drugs in much of sub-Saharan Africa. Previous findings suggest an association between resistance to CQ and to SP in vivo, in vitro, and on the molecular level. Methods: In 126 Ghanaian children with uncomplicated...

  • Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan. Ghanchi, Najia Karim; Ursing, Johan; Beg, Mohammad A.; Veiga, Maria I.; Jafri, Sana; Mårtensson, Andreas // Malaria Journal;2011, Vol. 10 Issue 1, p18 

    Background: Scarce data are available on Plasmodium falciparum anti-malarial drug resistance in Pakistan. The aim of this study was, therefore, to determine the prevalence of P. falciparum resistance associated polymorphisms in field isolates from southern Pakistan. Methods: Blood samples from...

  • Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania. Mbugi, Erasto V.; Mutayoba, Benezeth M.; Malisa, Allen L.; Balthazary, Sakurani T.; Nyambo, Thomas B.; Mshinda, Hassan // Malaria Journal;2006, Vol. 5, p1 

    Background: Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncomplicated Plasmodium falciparum malaria in many African countries. Nevertheless, the response of parasites to SP treatment has shown significant variation between individuals. Methods: The genes for...

  • Inbred parasites foil malaria drugs. Itzhaki, Jane // New Scientist;9/30/95, Vol. 147 Issue 1997, p19 

    Reports on the role of the mating habits of Plasmodium falciparum in the drug-resistance of malaria. Study on the occurrence of inbreeding and crossbreeding of P. falciparum; Differences in the breeding pattern of P. falciparum.

  • Chloroquine-resistant P. falciparum parasites and severe malaria in Orissa. Ranjit, M. R.; Sahu, U.; Khatua, C. R.; Mohapatra, B. N.; Acharya, A. S.; Kar, S. K. // Current Science (00113891);6/25/2009, Vol. 96 Issue 12, p1608 

    Malaria is one of the major causes of morbidity and mortality in Orissa. The present study was undertaken to measure the contribution of chloroquine (CQ) drug-resistant parasites to the risk of severe malaria and their biological advantage in this part of the country. Totally 79 uncomplicated...

  • Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum Ranford-Cartwright, L.C.; Johnston, K.L.; Abdel-Muhsin, A.M.; Khan, B.K.; Babiker, H.A. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Sep2002, Vol. 96 Issue 5, p568 

    We have critically evaluated 3 techniques for the detection of mutations conferring drug resistance of Plasmodium falciparum, using samples containing known numbers of well-characterized parasites and artificial mixtures of these parasites at known proportions. We compared the sensitivity and...

  • Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/ Myanmar: cross-sectional data and a systematic review of resistance studies. Brown, Tyler; Smith, Linda S.; Eh Kalu Shwe Oo; Kum Shawng; Lee, Thomas J.; Sullivan, David; Beyrer, Chris; Richards, Adam K. // Malaria Journal;2012, Vol. 11 Issue 1, p333 

    Background: Confirmation of artemisinin-delayed parasite clearance in Plasmodium falciparum along the Thai-Myanmar border has inspired a global response to contain and monitor drug resistance to avert the disastrous consequences of a potential spread to Africa. However, resistance data from...

  • Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Karyana, Muhammad; Burdarm, Lenny; Yeung, Shunmay; Kenangalem, Enny; Wariker, Noah; Maristela, Rilia; Umana, Ketut Gde; Vemuri, Ram; Okoseray, Maurits J.; Penttinen, Pasi M.; Ebsworth, Peter; Sugiarto, Paulus; Anstey, Nicholas M.; Tjitra, Emiliana; Price, Richard N. // Malaria Journal;2008, Vol. 7, Special section p1 

    Background: Multidrug resistance has emerged to both Plasmodium vivax and Plasmodium falciparum and yet the comparative epidemiology of these infections is poorly defined. Methods: All laboratory-confirmed episodes of malaria in Timika, Papua, Indonesia, presenting to community primary care...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics